Similarly, mutations like D116N/E and G120C/S, impacting the second GHR binding site (Chain C) and associated with IGHD1B or Kowarski Syndrome (D112G/H near this site), likely disrupt receptor dimerization essential for signaling. The gene discussed is GHR; the disease is short stature due to growth hormone qualitative anomaly.